Standards development for regenerative medicine therapies
Ended Purchase Order Awarded Last action
- Contract number
- 1333ND21PNB640152
- Awardee
-
Standards Coordinating Body For Gene Cell & Regenerative Medicines UEI D71MRJJYCVZ4
- Awarding agency
-
National Institute of Standards and Technology
Department of Commerce
- Obligated
- $1,091,420
Award facts
- Opportunity
-
- 1333ND21QNB640111 Solicitation number
- Contract value 49% obligated
-
- $1,091,420.00 Current, with exercised options
- $2,214,773.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 813920 Professional Organizations
- PSC
- AJ12 General Science And Technology R&D Services; General Science And Technology; Applied Research
- Set-aside
- No set-aside
- Competition
- 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Gaithersburg, MD 20899, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $115,472 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $267,240 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $359,351 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $349,357 |
About this award
The National Institute of Standards and Technology awarded a firm fixed-price purchase order to Standards Coordinating Body For Gene Cell & Regenerative Medicines for $2.214773 million on May 3, 2021, under Exercise Option III for standards development for regenerative medicine therapies. No set-aside applies. Work is performed in Gaithersburg, Maryland, with an ultimate completion date of May 2, 2026. The awardee is a non-profit organization specializing in standards development and educational initiatives within the regenerative medicine sector. In fiscal year 2024, the contract invoiced $156 thousand across 0.5 FTEs and 1,115 contractor hours at a derived government-paid rate of $140.30 per hour, with all work self-performed by the prime.
Quick answers
Who was awarded contract 1333ND21PNB640152?
1333ND21PNB640152 was awarded to Standards Coordinating Body For Gene Cell & Regenerative Medicines by National Institute of Standards and Technology (Department of Commerce) on May 3, 2021.
How much is contract 1333ND21PNB640152 worth?
The government has obligated $1,091,420 on 1333ND21PNB640152. Its potential value, with all options, is $2,214,773.
Was contract 1333ND21PNB640152 competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award